Document Detail


Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
MedLine Citation:
PMID:  2198314     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A controlled clinical trial of two multidrug regimens in multibacillary lepromatous and near-lepromatous patients with a bacterial index (BI) of 2.5 or more was conducted. Patients were randomly allocated to either a two-drug regimen of dapsone plus clofazimine for 60 months or a four-drug regimen of rifampin, isoniazid, dapsone, and clofazimine for the first 3 months and clofazimine plus dapsone for the next 57 months. There was no difference between the rifampin and nonrifampin regimens with respect to the clinical improvement or bacteriological status of the patients at 60 months. Reactive states and neuritis were observed to be equal in the two patient groups.
Authors:
A Thomas; A Balakrishnan; M Nagarajan; R Prabhakar; S P Tripathy; M Christian; P R Somasundaram
Related Documents :
8994754 - Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes...
9039174 - A multicenter, placebo-controlled, double-blind study of intermittent therapy with itra...
22244574 - No evidence for an anti-inflammatory effect of escitalopram intervention in healthy ind...
8482934 - Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical re...
1156214 - Treatment of "on-off effect" with a dopa decarboxylase inhibitor.
23797674 - Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the pro...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association     Volume:  58     ISSN:  0148-916X     ISO Abbreviation:  Int. J. Lepr. Other Mycobact. Dis.     Publication Date:  1990 Jun 
Date Detail:
Created Date:  1990-09-04     Completed Date:  1990-09-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8505819     Medline TA:  Int J Lepr Other Mycobact Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  273-80     Citation Subset:  IM    
Affiliation:
Tuberculosis Research Centre, Madras, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Clofazimine / therapeutic use
Dapsone / therapeutic use
Drug Therapy, Combination
Female
Humans
Infant, Newborn
Isoniazid / therapeutic use
Leprostatic Agents / therapeutic use*
Leprosy, Borderline / drug therapy*
Leprosy, Lepromatous / drug therapy*
Male
Randomized Controlled Trials as Topic
Rifampin / therapeutic use*
Chemical
Reg. No./Substance:
0/Leprostatic Agents; 13292-46-1/Rifampin; 2030-63-9/Clofazimine; 54-85-3/Isoniazid; 80-08-0/Dapsone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of heat and other agents on amino acid uptake in Escherichia coli.
Next Document:  Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.